Pharma breakthrough! BioIntelect to revolutionise trials using Opyl’s cutting-edge tech

By on    Pharma Industry News  

Pharma breakthrough! BioIntelect to revolutionise trials using Opyl’s cutting-edge tech

In a landmark collaboration, Opyl Limited announced a new six-month agreement with BioIntelect, a renowned Clinical Research Organisation (CRO) and strategic consulting firm in the life sciences industry. The partnership is set to revolutionise clinical trial outcomes through Opyl’s cutting-edge TrialKey platform, which offers data-driven biostatistical validation to optimise trial design. Key Points of the […]

Opyl Limited announces divestment of Opin to focus on AI-driven clinical trial management

By on    Healthcare Industry News, Technology Industry News  

Opyl Limited announces divestment of Opin to focus on AI-driven clinical trial management

Opyl Limited, listed on the Australian Securities Exchange under the ticker ASX:OPL, has entered a significant phase of corporate restructuring with the announcement of a non-binding offer from Trial Screen Pty Ltd, led by Dr. Hugo Stephenson, to acquire its patient candidate recruitment business, Opin. The proposed deal, which includes the divestment of Opin for […]